| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |